{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/ulcerative-colitis/background-information/complications/","result":{"pageContext":{"chapter":{"id":"5102ad12-cd60-5939-ad9a-00d4dafca9b0","slug":"complications","fullItemName":"Complications","depth":2,"htmlHeader":"<!-- begin field fec33db9-51a7-4ec6-b168-6986db22b988 --><h2>What are the complications?</h2><!-- end field fec33db9-51a7-4ec6-b168-6986db22b988 -->","summary":"","htmlStringContent":"<!-- begin item 07e877c8-a840-4be9-b7e3-5eb5abddf990 --><!-- begin field a6674fb7-b257-47f7-ab6c-4c894daea835 --><p><strong>Complications of ulcerative colitis include:</strong></p><ul><li>Psychosocial impact — the unpredictability of symptoms and embarrassment due to faecal urgency or frequency may affect daily functioning, including quality of life at school, work, or with leisure activities.</li><li>Toxic megacolon — a potentially life-threatening complication of segmental or total non-obstructive dilatation of the colon accompanied by escalating abdominal pain and systemic symptoms, which may require colectomy. Typically there is dilatation of the transverse colon on abdominal X-ray. It may occur spontaneously as a result of relapse, or be precipitated by infection, hypokalaemia, hypomagnesaemia, medical bowel preparation, or the use of anti-diarrhoeal drugs.</li><li>Bowel obstruction — suggested by lack of passing stool or flatus, abdominal pain, distension, or vomiting.</li><li>Bowel perforation — may complicate acute severe colitis and may be associated with inappropriate total colonoscopy investigation or toxic megacolon if colectomy has been inappropriately delayed.</li><li>Intestinal strictures — where the intestine narrows and partially or completely obstructs the passage of bowel contents. In longstanding ulcerative colitis, a colonic stricture is suggestive of colorectal cancer. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gastrointestinal-tract-lower-cancers-recognition-referral/\">Gastrointestinal tract (lower) cancers - recognition and referral</a> for more information. </li><li>Fistulas — simple fistulae may occasionally occur in ulcerative colitis, where the bowel wall is perforated, allowing faecal matter to track through to adjacent organs, such as the intestine, bladder, vagina, abdominal wall, or perianal skin.</li><li>Anaemia — may be due to iron deficiency (through blood loss or nutritional deficiency), anaemia of chronic disease, or drug-associated anaemia. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a> for more information.</li><li>Malnutrition, faltering growth, and delayed pubertal development (in children) — may be due to reduced oral intake, increased nutrient requirements, increased gastrointestinal losses and malabsorption, long-term corticosteroid use, and drug-nutrient interactions. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/faltering-growth/\">Faltering growth</a> for more information.</li><li>Growth failure —  this is seen in about 10% of children with ulcerative colitis, and the cause is multifactorial including decreased intake, increased metabolic demand, malabsorption, and corticosteroid drug treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Rosen, 2015</a>].</li><li>Colorectal cancer — a meta-analysis of eight European population-based cohort studies calculated pooled standardized incidence ratios of ulcerative colitis (based on relatively low absolute numbers), with a cumulative incidence of colorectal cancer of less than 1% at 10 years, 0.4%–2.0% at 15 years, and 1.1–2.5% at 20 years. It concluded that ulcerative colitis increases the risk of colorectal cancer 2.4-fold [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Jess, 2005</a>]. The risk is increased in people with disease diagnosed in childhood, those with a long disease duration, co-morbid primary sclerosing cholangitis, or a family history of colorectal cancer in a first-degree relative aged under 50 years. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gastrointestinal-tract-lower-cancers-recognition-referral/\">Gastrointestinal tract (lower) cancers - recognition and referral</a> for more information.</li><li>Pouchitis — this may complicate 30% of colectomy cases, and presents with increased stool frequency, urgency, faecal incontinence, and nocturnal seepage. It is usually treated with antibiotics such as metronidazole and ciprofloxacin.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Mowat et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">NICE, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Ford, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Annese, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Rosen, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Harbord, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Forbes, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Harbord, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Magro, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Oliveira, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ulcerative-colitis/references/\">Turner, 2018b</a>]</p><!-- end field a6674fb7-b257-47f7-ab6c-4c894daea835 --><!-- end item 07e877c8-a840-4be9-b7e3-5eb5abddf990 -->","topic":{"id":"34aee656-b482-5065-8656-44c487e4e347","topicId":"6a63bd87-53c1-487d-8426-773cffdb4c43","topicName":"Ulcerative colitis","slug":"ulcerative-colitis","lastRevised":"Last revised in April 2020","chapters":[{"id":"8ec19c69-a796-514b-a267-91bd57a12fe3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"dc4de3c1-9955-536e-9789-a900261d2189","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"04875f8c-29b3-5d60-8e5c-06930138cfc4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"04f00df3-2de5-5c61-bb95-25edda5f885b","slug":"changes","fullItemName":"Changes"},{"id":"12402ddb-2eb9-589e-a1c3-24d50e2538f8","slug":"update","fullItemName":"Update"}]},{"id":"2c186889-f3c1-5094-b0ce-0b9a81f46d61","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"36a3da73-b00f-5ee2-bfd9-33293a674904","slug":"goals","fullItemName":"Goals"},{"id":"5c86e0bc-3476-59dd-b120-519602968645","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3ab8e65e-aac9-54a1-abb3-9185c76c6004","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0efa89a1-51f7-59ff-95ce-94faac48f8a5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a2b17331-6cfc-56eb-84c5-433f78f4364c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"01a70081-193a-5d75-92fb-45f84ee7b317","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"87cfff6e-6028-5fda-aee6-4473268cac77","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"116a07eb-6832-5d49-aa1d-497f7c0684a9","slug":"definition","fullItemName":"Definition"},{"id":"fef2143b-1809-58f3-bdf9-0d73710d89ae","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"9c9a2e21-7e98-5876-945d-ec18ebfaee62","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5102ad12-cd60-5939-ad9a-00d4dafca9b0","slug":"complications","fullItemName":"Complications"},{"id":"488ac85b-91d2-5298-9127-69ae212ceeac","slug":"extra-intestinal-manifestations","fullItemName":"Extra-intestinal manifestations"},{"id":"9ff94ba6-78d6-5ed0-9cda-f234b24236d7","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"2149059a-c90f-50e5-9fa2-227a488d2004","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"40b81845-1ebc-55b2-b825-05a3d62e3cc4","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"0102b680-c790-5c87-aaec-ea332f5fc9b2","slug":"investigations","fullItemName":"Investigations"},{"id":"2ea841c6-272f-5b4b-a165-499ec0228439","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"468c6dcc-e9f2-5154-9f2b-30d7dafb7415","fullItemName":"Management","slug":"management","subChapters":[{"id":"6a9b8b90-a418-5e1b-9442-ac55ee36430f","slug":"suspected-ulcerative-colitis","fullItemName":"Scenario: Suspected ulcerative colitis"},{"id":"6d8002d3-29fe-5bfd-ba03-7ce0173636e4","slug":"confirmed-ulcerative-colitis","fullItemName":"Scenario: Confirmed ulcerative colitis"},{"id":"56868b16-5233-5bb8-9412-d2d9bfafe8d9","slug":"fertility-pregnancy-breastfeeding-with-ulcerative-colitis","fullItemName":"Scenario: Fertility, pregnancy, and breastfeeding with ulcerative colitis"},{"id":"7708c2de-0c02-5b83-a354-70788b3dc297","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"010b277d-6575-5cdc-b995-6fc7d89fb745","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a8ed7157-985a-58a5-b567-571fa748a73b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a1164542-c6ec-5b63-bfee-efc59657c778","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"568370d3-2e5b-55a4-ae50-2eeeb5ca3234","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"df1aecf8-eeb0-5069-965e-21ccf0690af8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"889198a1-b809-54b2-b803-3ee02e6f45af","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a290d39a-e351-5dec-9607-943a59e60b2e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"916d81a4-ae1e-529e-936f-183b4514ba9f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"87cfff6e-6028-5fda-aee6-4473268cac77","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}